Pharmacokinetic Properties of Polyethylene Glycol Derivatized Superoxide Dismutase
Overview
Authors
Affiliations
Xiong C, Wulff J, Nachman R, Pietrantonio P Front Physiol. 2022; 12:826399.
PMID: 35242048 PMC: 8887807. DOI: 10.3389/fphys.2021.826399.
Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.
Parveen S, Sahoo S Clin Pharmacokinet. 2006; 45(10):965-88.
PMID: 16984211 DOI: 10.2165/00003088-200645100-00002.
Krasowska A, Piasecki A, Polinceusz A, Prescha A, Sigler K Folia Microbiol (Praha). 2006; 51(2):99-107.
PMID: 16821718 DOI: 10.1007/BF02932163.
N-terminal site-specific mono-PEGylation of epidermal growth factor.
Lee H, Jang I, Ryu S, Park T Pharm Res. 2003; 20(5):818-25.
PMID: 12751640 DOI: 10.1023/a:1023402123119.
Preformulation development of recombinant pegylated staphylokinase SY161 using statistical design.
Bedu-Addo F, Moreadith R, Advant S AAPS PharmSci. 2003; 4(4):E19.
PMID: 12645991 PMC: 2751308. DOI: 10.1208/ps040419.